In 2025, data protection is more important than ever. Yet, many in the pharma industry are still behind when it comes to applying GDPR principles at events and tradeshows. With... In today’s ...

The drug is now the first-ever therapy approved in the US for MAS in patients with Still's disease The US Food and Drug Administration (FDA) has approved Sobi’s Gamifant (emapalumab-lzsg) as the first ...